Delivery Order SPE2DB22D3010-SPE2DB24FP3AX

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $3,156.00 delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military treatment facilities and other federal healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,026.03 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a period of performance through July 15, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,260.00 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for the supply of 4565629840 - MOUNJARO 15 MG/0.5 ML PEN 0.5ML. This contract has an ultimate completion date of August 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025...
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract worth $2,630.00 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $18,358.36 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the procurement of the drug MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This award is part of AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a $999,999,999 contract vehicle that provides a comprehensive range of pharmaceutical products and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,257.52, is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a $1,062.76 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4564480092 - MOUNJARO 10 MG/0.5 ML PEN 0.5ML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $18,665.10 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has a completion date of November 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $3,156.00, has a firm fixed price pricing type and an ultimate completion date of July 10, 2024. This award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $10,170.76 award has a completion date of March 7, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB24FP3AX
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $5,523 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565440991 - MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award has an ultimate completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/12/24, 9:03 AM